Some U.S. Bishops Advise Catholics to Avoid J&J Vaccine
(Bloomberg) -- Some U.S. bishops are advising Catholics to avoid what the prelates contend is a Johnson & Johnson Covid-19 vaccine that's immoral because aborted human tissue is used in its manufacture. Their guidance is stricter than the Vatican's declaration that the formula is broadly acceptable for the faith's 1.3 billion followers.
The Archdiocese of St. Louis, known as the “Rome of the West” for its size and influence, on Tuesday urged its 500,000 members to choose shots by Moderna Inc. and Pfizer Inc., but to go with J&J “in good conscience if no other alternative is available.”
The Archdiocese of New Orleans, with 518,000 Catholics, was more forceful. In a Feb. 26 statement, it cited “the wrongdoing” of the vaccine's creators for the “extensive use of abortion-derived cell lines.” The two archdioceses declared the formula “morally compromised.”
Asked to comment, Sarah McDonald, a New Orleans archdiocese spokeswoman, emailed a portion of the guidance: “If the Moderna or Pfizer vaccine is available, Catholics should choose to receive either of those vaccines rather than to receive the new Johnson & Johnson vaccine because of its extensive use of abortion-derived cell lines.”
The U.S. coronavirus death toll on Feb. 22 surpassed 500,000 as Catholics worldwide observed Lent, the season that precedes Easter, the Church's holiest day. Almost 25% of Americans identify as Roman Catholic, according to a 2018 Gallup Poll.
Vaccine Morality
The sanctity of life is central to global church teaching, and abortion is considered a grave sin, even if the fetus is the result of rape or the expectant mother's life is in danger. On Dec. 21, though, the Vatican -- the center of Catholic rule -- declared that Covid-19 vaccines tied to abortion “can be used in good conscience.”
“The morality of the vaccination depends not only on the duty to protect one's own health, but also on the duty to protect the common good,” according to a statement ordered to be published by Pope Francis.
In the absence of choices, “It is morally acceptable to receive Covid-19 vaccines that have used cell lines from aborted fetuses in their research and production process.”
J&J's product is the third to enter the U.S. market after its approval by the Food and Drug Administration on Saturday. The formula, which doesn't need freezer storage and is one shot as opposed to its rivals' two, will ease broader distribution and faster population immunity. Its addition, with manufacturing help from Merck & Co., means that enough vaccine doses will be on hand by the end of May for every American adult, said President Joe Biden, who is Catholic.
Balancing Faith, Health
The development of all three vaccines relied on cells from aborted fetal tissue, though none has that ingredient in the shots. The product by New Brunswick, New Jersey-based J&J differs because the cells are used during production.
“We are able to manufacture hundreds of millions of doses using our engineered cell-line system and look forward to delivering those doses around the world and help meet the critical need,” spokesperson Lisa Cannellos said in a statement.
The U.S. Conference of Catholic Bishops, in a statement issued Tuesday, said that if one has the choice, it should be “the vaccine with the least connection to abortion-derived cell lines.”
“While we should continue to insist that pharmaceutical companies stop using abortion-derived cell lines, given the world-wide suffering that this pandemic is causing, we affirm again that being vaccinated can be an act of charity that serves the common good,” read the statement, by Bishop Kevin Rhoades of Fort Wayne-South Bend and Archbishop Joseph Naumann of Kansas City, Kansas.
Maria Lemakis, a spokesperson for the St. Louis Archdiocese, said in an email that no one was available to comment but that its J&J statement is aligned with that of the bishops group, “which also is in line with the Vatican's guidance from December.”
©2021 Bloomberg L.P.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.